AZTR•benzinga•
Azitra To Present Data Highlighting Phase 1/2 Clinical Trial Of ATR04-484 In EGFR Inhibitor-Associated Rash At 2025 ASCO Annual Meeting
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 28, 2025 by benzinga